Message Font: Serif | Sans-Serif
No. of Recommendations: 3
Look, this is a developmental company--we should not be in it to watch it daily-----we are betting and I use the term betting on purpose---that their drug wil "hit pay dirt"---if they do the add'l shares/debt
will be a footnote
Print the post Back To Top
No. of Recommendations: 1
My thoughts are this is probably the last offering. I think Cabo will be a go or a no go with the FDA within a year. If Cabo is a go, the money raised will be useful in marketing Cabo. If it's a no go, then that's all she wrote....
Print the post Back To Top
No. of Recommendations: 10
It is a go with the FDA. The full data set is still being produced and is not known such as overall survival. But progression free survival, if memory serves (and mine is pretty good) was 27 or 28% for CABO and 0% for placebo.

That is not a fluke. That is efficacy. If that is not efficacy, then we better redefine the term.

MTC is a small market though, and the marketing costs for it will be small. All practitioners for MTC cases will know of it in the U.S. and it will largely be production and distribution issues. Some marketing vs. one competitor that has little to offer efficacy wise. Perhaps it won't match up well in the end, perhap sit will be clearly superior not known. But it does work. And seems to work better than anything else in the indication.

But no, the money will be used for clinical trials for CABO in larger indications. True, there are issues of, will it produce overall survival in these indications, and if so, will there still be room for it as a market leader. The former I believe yes, the latter is what the uncertainty mostly surrounds I think. Time to market. The drug is clearly differentiated, but the uncertainty is, are the bone scans clinically meaningful. Who knows, but it seems quite likely that it is.

The $225 million convertible hits in 2019. That convertible would presently, as of close today, be nearly a 1/3 dilution of the shares. Where as the secondary itself is about 12-13% or thereabouts. By 2019, if Cabo is not on the market for prostate and then another major indication, the drug will have been a total flop anyways. If it is on the market for prostate (even iwthout another major indication) it will have a multi-billion dollar market cap and the 225 million convertible secondary will be small time dilution at that point in time.

Is there something in the contractual terms of the convertible that make its dilutive effect in 2019 much greater than just the $225 million? I have not looked at that detail. Assuming it is just $225 million, it won't be a problem by 2019. And if it is, most of us won't care anyways as Cabo will have been a failure.

Long and short, this sell off does not fully make sense, absence a technical sell off allowing short to get away with it, just as the share price increased as well into it, and outside a 6 month purview is ridiculous.

More so when one figures, as you do, that yes, this is likely the last fund raising event for the company, at least until the share price is much higher on either anticipated or actual drug approval, or bust. One or the other.

Temporarally displaced from the answer.

Just as we are temporally displaced from the election. I won't be here if Obama wins, but just in case Romney does, I'll keep this one bookmarked and see how it turns out on this board.

If Obama wins, I am just cashing out, paying off the house, all the debt, and basically saying screw it. Why even try anymore. Which is what is going to happen in France when they put in the 75% tax rate. If everything is available for free, and if your hardwork is literally stolen like that, then why not just grab a beer, say let the other guy work, and watch the whole system crash around you. Maybe go into politics, as in Obama's America, only politicians are noble, not business people, entrepreneurs, and those that actually produce. They are the oppressors. Sad to say this about any American president, and I never thought we would see the day.
Print the post Back To Top
No. of Recommendations: 7
Found your post interesting until it turned political. I will no longer be reading your posts.
Print the post Back To Top
No. of Recommendations: 6
Bye Scarver.

Print the post Back To Top
No. of Recommendations: 2
Here's hoping you have better judgment about drug companies than politics.

Maine has some good places to create an outpost from civilization, but it's cold and most people find their neighbors who don't have anger management problems worthwhile, even the liberals and even the anarchists.

Good luck.
Print the post Back To Top